(Q42504152)

1 November 2017

0 references

Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis (English)

1 reference

1 November 2017

Changjun Wang

1

1 reference

1 November 2017

Hanjiang Zhu

2

1 reference

1 November 2017

Yidong Zhou

3

1 reference

1 November 2017

Feng Mao

4

1 reference

1 November 2017

Yan Lin

5

1 reference

1 November 2017

Bo Pan

6

1 reference

1 November 2017

Xiaohui Zhang

7

1 reference

1 November 2017

Qianqian Xu

8

1 reference

1 November 2017

Xin Huang

9

1 reference

1 November 2017

Qiang Sun

10

1 reference

1 November 2017

12 January 2017

1 reference

1 November 2017

1 reference

1 November 2017

23

1 reference

1 November 2017

4

1 reference

1 November 2017

436-443

1 reference

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 November 2017

1 reference

PD-1 and PD-1 ligands: from discovery to clinical application

21 January 2018

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

PD-L1 expression in triple-negative breast cancer

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma

21 January 2018

1 reference

PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer

21 January 2018

1 reference

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

21 January 2018

1 reference

PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival

21 January 2018

1 reference

Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.

21 January 2018

1 reference

Cancer immunotherapy comes of age

21 January 2018

1 reference

PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

21 January 2018

1 reference

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

21 January 2018

1 reference

Prognostic and predictive value of PDL1 expression in breast cancer

21 January 2018

1 reference

In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas

21 January 2018

1 reference

High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer

21 January 2018

1 reference

Prognostic significance of PD-L1 and PD-L2 in breast cancer

21 January 2018

1 reference

Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer

21 January 2018

1 reference

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

21 January 2018

1 reference

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

21 January 2018

1 reference

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

21 January 2018

1 reference

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes.

21 January 2018

1 reference

21 January 2018

1 reference

The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.

21 January 2018

1 reference

The prognostic value of PD-L1 expression for non-small cell lung cancer patients: a meta-analysis.

21 January 2018

1 reference

Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis

21 January 2018

1 reference

Programmed death ligand-1 expression in non-small cell lung cancer

21 January 2018

1 reference

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TBJ.12753

1 reference

1 November 2017

1 reference